+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Revvity Inc (RVTY) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 83 Pages
  • September 2023
  • GlobalData
  • ID: 5877303
Revvity Inc (RVTY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Revvity Inc (Revvity) offers products, services, and solutions for the diagnostics, life sciences, and applied markets. The company offers reagents, instruments, assay platforms and software to hospitals, clinicians, medical labs and medical research professionals. Revvity also offers cord blood and tissue banking, laboratory and research services. Its products find application in atomic spectroscopy, cell imaging and analysis, chromatography, analysis and detection, DNA/RNA isolation, in vivo imaging, molecular spectroscopy, protein analysis and detection, and tissue imaging, among others. The company operates in Asia, Europe and Americas. Revvity is headquartered in Waltham, Massachusetts, the US.

Revvity Inc Key Recent Developments

  • Jul 27, 2023: Revvity Signals Software and Scitara Expand Strategic Relationship to Accelerate Laboratory Digital Transformation
  • Jul 12, 2023: Revvity to Hold Earnings Call on Tuesday, August 1, 2023
  • Mar 09, 2023: PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
  • Feb 27, 2023: PerkinElmer unveils multimode plate reader to expedite drug discovery

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Revvity Inc - Key Facts
  • Revvity Inc - Key Employees
  • Revvity Inc - Key Employee Biographies
  • Revvity Inc - Major Products and Services
  • Revvity Inc - History
  • Revvity Inc - Company Statement
  • Revvity Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Revvity Inc - Business Description
  • Business Segment: Diagnostics
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Discovery & Analytical Solutions
  • Overview
  • Performance
  • Key Stats
  • Geographical Segment: Americas
  • Performance
  • Geographical Segment: Asia
  • Performance
  • Geographical Segment: Europe
  • Performance
  • R&D Overview
  • Revvity Inc - Corporate Strategy
  • Revvity Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Revvity Inc - Strengths
  • Revvity Inc - Weaknesses
  • Revvity Inc - Opportunities
  • Revvity Inc - Threats
  • Revvity Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Revvity Inc, Medical Equipment, Deals By Year, 2017 to YTD 2023
  • Revvity Inc, Medical Equipment, Deals By Type, 2017 to YTD 2023
  • Revvity Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jul 27, 2023: Revvity Signals Software and Scitara Expand Strategic Relationship to Accelerate Laboratory Digital Transformation
  • Jul 12, 2023: Revvity to Hold Earnings Call on Tuesday, August 1, 2023
  • Mar 09, 2023: PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
  • Feb 27, 2023: PerkinElmer unveils multimode plate reader to expedite drug discovery
  • Feb 24, 2023: PerkinElmer launches EnVison Nexus multimode plate reader to drive improved research and discovery workflows
  • Nov 21, 2022: PerkinElmer helps accelerate gene therapy research with industry-first ready-to-use viral vector assays
  • Nov 08, 2022: PerkinElmer Announces Financial Results for the Third Quarter of 2022
  • Oct 19, 2022: Medical Device Innovation Consortium (MDIC) partners with PerkinElmer's Horizon Discovery to improve accuracy of next generation sequencing-based cancer diagnostics
  • Oct 13, 2022: PerkinElmer Donation Helps Significantly Expand Capacity for Sickle Cell Disease Screening in Ghana
  • Sep 27, 2022: PerkinElmer launches Cellaca PLX image cytometry system
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Revvity Inc, Key Facts
  • Revvity Inc, Key Employees
  • Revvity Inc, Key Employee Biographies
  • Revvity Inc, Major Products and Services
  • Revvity Inc, History
  • Revvity Inc, Other Locations
  • Revvity Inc, Subsidiaries
  • Revvity Inc, Joint Venture
  • Revvity Inc, Key Competitors
  • Revvity Inc, Ratios based on current share price
  • Revvity Inc, Annual Ratios
  • Revvity Inc, Interim Ratios
  • Revvity Inc, Medical Equipment, Deals By Year, 2017 to YTD 2023
  • Revvity Inc, Medical Equipment, Deals By Type, 2017 to YTD 2023
  • Revvity Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Revvity Inc, Performance Chart (2018 - 2022)
  • Revvity Inc, Ratio Charts
  • Revvity Inc, Medical Equipment, Deals By Year, 2017 to YTD 2023
  • Revvity Inc, Medical Equipment, Deals by Type, 2017 to YTD 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Precipio Inc
  • MilliporeSigma
  • Spectris Plc
  • Harvard Bioscience Inc
  • Beckman Coulter Inc
  • Thermo Fisher Scientific Inc
  • Bio-Rad Laboratories Inc
  • Shimadzu Corp